Company to Highlight Imaging Biomarkers for Cytoprotection and Post Hoc Analysis from Phase 2 RESCUE Clinical Trial; RNS60 ...

Please provide your email address to receive an email when new articles are posted on . Researchers engaged in a secondary analysis of the ESCAPE clinical trial in patients with acute ischemic stroke.

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

HELSINKI, Finland—Adding IV tirofiban improves functional outcomes among patients undergoing systemic thrombolysis for acute ischemic stroke within 4.5 hours of symptom onset, results from the ...

In OCEANIC-STROKE, patients who received asundexian after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack were significantly less likely to suffer a secondary stroke ...

Stroke is the leading cause of long-term disability and preventable disability in the United States. It is also the fifth leading cause of death, killing nearly 130,000 people in the U.S. each year.

Specialized physical therapy plays a defining role in post-stroke recovery, influencing mobility, independence and long-term quality of life. For health care leaders and clinicians, referral decisions ...

Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...

For many people, leaving the hospital isn't the end of a health journey; instead, it's the start of ongoing care. Whether that's physical therapy after surgery or occupational and speech therapy ...